How to work with us
VaxWave®* is a replication-defective arenavirus which induces a strong immune response for prophylactic use against infectious disease. TheraT®* is a replication-attenuated arenavirus which produces an even more powerful immune response that enables HOOKIPA to develop immuno-oncology therapies and therapeutic vaccines.
We have forged a partnership with Gilead to develop immunotherapies against HIV and Hepatitis B. To learn more about our partnership with Gilead please see this Press Release. We are open for further strategic partnerships which reflect the potential of the technology, provide performance related downstream revenues while preserving growth opportunities for HOOKIPA in the future.
Please contact our Business Development & Licensing Team with any inquiries.
We look forward to hearing from you!
*Registered in Europe; Pending in the US